Jiangsu Aidea Pharmaceutical (688488.SS) Earnings Analysis

Jiangsu Aidea Pharmaceutical (688488.SS) has no confirmed upcoming earnings date. Trailing P/E -94.38.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does 688488.SS next report earnings?

No confirmed upcoming earnings date is currently scheduled for 688488.SS. This page updates as the calendar is published.

688488.SS earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2025-10-31-0.0381 CNYn/an/an/a
2024-12-31-0.1652 CNYn/an/an/a
2024-10-30-0.03685 CNYn/an/an/a
2024-08-22-0.07564 CNYn/an/an/a

688488.SS valuation and analyst view

Trailing P/E-94.38
Trailing EPS-0.06585 CNY
Price / book6.82
Dividend yield0.00%
Market cap6.66B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is Jiangsu Aidea Pharmaceutical (688488.SS)'s next earnings date?

No confirmed upcoming earnings date is currently scheduled for 688488.SS. This page updates as the calendar is published.

Did 688488.SS beat earnings last quarter?

Consensus estimate data was not available for 688488.SS's 2025-10-31 report.

What is 688488.SS's current P/E ratio and EPS?

688488.SS trades at a trailing P/E of -94.38 on trailing EPS of -0.06585208443211872 CNY.

What do analysts rate 688488.SS?

688488.SS has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.